The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Tumor microenvironmental physiology and its implications for radiation oncology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
(1989) · PubMed · Cited by 3,343
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Self-citationGray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Self-citationBusch, H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00015 · Cited by 1,205
(1996) · PubMed · Cited by 1,188
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
Cited by
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Self-citationDrug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Vaupel, P., Schmidberger, H., & Mayer, A. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1589653 · Cited by 893
Self-citationGold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865
Revisiting the Warburg effect: historical dogma versus current understanding
Vaupel, P., & Multhoff, G. (2021) · The Journal of Physiology · doi:10.1113/jp278810 · Cited by 830
Self-citationBrahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0281-3 · Cited by 765
“In addition, cells that survive acidosis not only develop a growth advantage but also become more aggressive and invasive [6, 44].”
BackgroundDetection and Characterization of Tumor Hypoxia Using pO 2 Histography
Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728
Self-citationXia, Q., Zhang, Y., Li, Z., Hou, X., & Feng, N. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.011 · Cited by 665
Gao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 590
A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle
Amina, S. J., & Guo, B. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s279094 · Cited by 561
Hyperthermia adds to chemotherapy
Issels, R. D. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.038 · Cited by 545
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Rockwell, S., Dobrucki, I., Kim, E., Marrison, S., & Vu, V. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167087 · Cited by 511
Fokas, E., Liersch, T., Fietkau, R., Hohenberger, W., Beissbarth, T., Hess, C., Becker, H., Ghadimi, M., Mrak, K., Merkel, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.3769 · Cited by 454
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 443
Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J., Foretz, M., & Viollet, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-06 · Cited by 442
Unimolecular Photodynamic O2-Economizer To Overcome Hypoxia Resistance in Phototherapeutics
Li, M., Shao, Y., Kim, J. H., Pu, Z., Zhao, X., Huang, H., Xiong, T., Kang, Y., Li, G., Shao, K., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00734 · Cited by 397
Oxygen, a source of life and stress
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.018 · Cited by 383
The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease
Giaccia, A. J., Simon, M. C., & Johnson, R. (2004) · Genes & Development · doi:10.1101/gad.1243304 · Cited by 380
Signalling via integrins: Implications for cell survival and anticancer strategies
Hehlgans, S., Haase, M., & Cordes, N. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.09.001 · Cited by 373
Cairns, R., Papandreou, I., & Denko, N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0002 · Cited by 370
Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent
de Oliveira, J. R., Camargo, S. E. A., & de Oliveira, L. D. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0499-8 · Cited by 367
Emerging roles of ECM remodeling processes in cancer
Mohan, V., Das, A., & Sagi, I. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.004 · Cited by 334
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00153 · Cited by 332
Chan, N., Koritzinsky, M., Zhao, H., Bindra, R., Glazer, P. M., Powell, S., Belmaaza, A., Wouters, B., & Bristow, R. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5472 · Cited by 328
Ph-responsive polymer–drug conjugates: design and progress
Pang, X., Jiang, Y., Xiao, Q., Leung, A. W., Hua, H., & Xu, C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.024 · Cited by 317
Debele, T. A., Mekuria, S. L., & Tsai, H.-C. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.121 · Cited by 317
Extracellular vesicles in the tumor microenvironment: old stories, but new tales
Han, L., Lam, E. W.-F., & Sun, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0980-8 · Cited by 294
Cancer stem cells: A review from origin to therapeutic implications
Atashzar, M. R., Baharlou, R., Karami, J., Abdollahi, H., Rezaei, R., Pourramezan, F., & Zoljalali Moghaddam, S. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29044 · Cited by 281
Tumor Metabolism of Lactate: The Influence and Therapeutic Potential for MCT and CD147 Regulation
Kennedy, K. M., & Dewhirst, M. W. (2010) · Future Oncology · doi:10.2217/fon.09.145 · Cited by 280
Kung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277
“But tumor cells tend to favor glycolysis even with the availability of oxygen, hence termed ‘‘aerobic glycolysis’’ [19].”
BackgroundDynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy
Zahra, M. A., Hollingsworth, K. G., Sala, E., Lomas, D. J., & Tan, L. T. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(06)71012-9 · Cited by 272
Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
Zinn, P. O., Majadan, B., Sathyan, P., Singh, S. K., Majumder, S., Jolesz, F. A., & Colen, R. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025451 · Cited by 265
Li, J., Li, Y., Wang, Y., Ke, W., Chen, W., Wang, W., & Ge, Z. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03531 · Cited by 263
Marie-Egyptienne, D. T., Lohse, I., & Hill, R. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.019 · Cited by 256
Significance of nitroimidazole compounds and hypoxia‐inducible factor‐1 for imaging tumor hypoxia
Kizaka‐Kondoh, S., & Konse‐Nagasawa, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01195.x · Cited by 255
Cancer stem cells and radioresistance
Rycaj, K., & Tang, D. G. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892227 · Cited by 254
Ke, W., Li, J., Mohammed, F., Wang, Y., Tou, K., Liu, X., Wen, P., Kinoh, H., Anraku, Y., Chen, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b09082 · Cited by 254
Franovic, A., Gunaratnam, L., Smith, K., Robert, I., Patten, D., & Lee, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702387104 · Cited by 250
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
Palazón, A., Aragonés, J., Morales-Kastresana, A., de Landázuri, M. O., & Melero, I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1591 · Cited by 214
Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer
Kennedy, K. M., Scarbrough, P. M., Ribeiro, A., Richardson, R., Yuan, H., Sonveaux, P., Landon, C. D., Chi, J.-T., Pizzo, S., Schroeder, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075154 · Cited by 190
Modulation of the tumor vasculature and oxygenation to improve therapy
Siemann, D. W., & Horsman, M. R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.006 · Cited by 169
Myeloid cell heterogeneity in cancer: not a single cell alike
Kiss, M., Van Gassen, S., Movahedi, K., Saeys, Y., & Laoui, D. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.008 · Cited by 159
Crawford, S. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00068 · Cited by 108
Cell Volume Regulation in Epithelial Physiology and Cancer
Pedersen, S. F., Hoffmann, E. K., & Novak, I. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00233 · Cited by 94
“This has been shown directly for breast cancer (Vaupel, 2004), whereas evidence is more sparse for PDAC (see Feig et al., 2012).”
InfluentialExploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
Vaupel, P., & Multhoff, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01887 · Cited by 81
“Tumor microvessels show many structural and functional abnormalities (5).”
BackgroundSelf-citationThree Dimensional Microfluidic Cell Arrays for ex Vivo Drug Screening with Mimicked Vascular Flow
Dereli-Korkut, Z., Akaydin, H. D., Ahmed, A. H. R., Jiang, X., & Wang, S. (2014) · Analytical Chemistry · doi:10.1021/ac403899j · Cited by 62
Xiang, Z.-L., Zeng, Z.-C., Fan, J., Tang, Z.-Y., He, J., Zeng, H.-Y., & Chang, J. Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-011-0949-1 · Cited by 52
Fay, M. M., Clegg, J. M., Uchida, K. A., Powers, M. A., & Ullman, K. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541300 · Cited by 30
Metadata
- Authors
- Vaupel, P.
- Venue
- Seminars in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 14
- Issue
- 3
- Pages
- 198-206
- ISSN
- 1053-4296 (ISSN-L)
- OpenAlex
- W2007287727
- Cited by
- 947
- References
- 55
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.